Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.

Literature DB >> 21842440

Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.

Roberto Cilia, Francesca Sironi, Albert Akpalu, Momodou Cham, Fred Stephen Sarfo, Tiziana Brambilla, Alba Bonetti, Marianna Amboni, Stefano Goldwurm, Gianni Pezzoli.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 21842440 DOI： 10.1007/s00415-011-6210-y

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

9 in total

1. Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.

Authors: C P Zabetian; H Morino; H Ujike; M Yamamoto; M Oda; H Maruyama; Y Izumi; R Kaji; A Griffith; B C Leis; J W Roberts; D Yearout; A Samii; H Kawakami
Journal: Neurology Date: 2006-05-25 Impact factor: 9.910

Review 2. The genetics of Parkinson disease: Implications for neurological care.

Authors: Christine Klein; Michael G Schlossmacher
Journal: Nat Clin Pract Neurol Date: 2006-03

3. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.

Authors: Soraya Bardien; Angelica Marsberg; Rowena Keyser; Debbie Lombard; Suzanne Lesage; Alexis Brice; Jonathan Carr
Journal: J Neural Transm (Vienna) Date: 2010-06-11 Impact factor: 3.575

4. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

Authors: Cyrus P Zabetian; Carolyn M Hutter; Dora Yearout; Alexis N Lopez; Stewart A Factor; Alida Griffith; Berta C Leis; Thomas D Bird; John G Nutt; Donald S Higgins; John W Roberts; Denise M Kay; Karen L Edwards; Ali Samii; Haydeh Payami
Journal: Am J Hum Genet Date: 2006-08-17 Impact factor: 11.025

5. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.

Authors: Alessio Di Fonzo; Christan F Rohé; Joaquim Ferreira; Hsin F Chien; Laura Vacca; Fabrizio Stocchi; Leonor Guedes; Edito Fabrizio; Mario Manfredi; Nicola Vanacore; Stefano Goldwurm; Guido Breedveld; Cristina Sampaio; Giuseppe Meco; Egberto Barbosa; Ben A Oostra; Vincenzo Bonifati
Journal: Lancet Date: 2005 Jan 29-Feb 4 Impact factor: 79.321

6. Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.

Authors: S Lesage; C Condroyer; A Lannuzel; E Lohmann; A Troiano; F Tison; P Damier; S Thobois; A-M Ouvrard-Hernandez; S Rivaud-Péchoux; C Brefel-Courbon; A Destée; C Tranchant; M Romana; L Leclere; A Dürr; A Brice
Journal: J Med Genet Date: 2009-04-08 Impact factor: 6.318

7. A common LRRK2 mutation in idiopathic Parkinson's disease.

Authors: William P Gilks; Patrick M Abou-Sleiman; Sonia Gandhi; Shushant Jain; Andrew Singleton; Andrew J Lees; Karen Shaw; Kailash P Bhatia; Vincenzo Bonifati; Niall P Quinn; John Lynch; Daniel G Healy; Janice L Holton; Tamas Revesz; Nicholas W Wood
Journal: Lancet Date: 2005 Jan 29-Feb 4 Impact factor: 79.321

8. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease.

Authors: S Goldwurm; M Zini; L Mariani; S Tesei; R Miceli; F Sironi; M Clementi; V Bonifati; G Pezzoli
Journal: Neurology Date: 2007-01-10 Impact factor: 9.910

9. Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3.

Authors: Njideka Okubadejo; Angela Britton; Cynthia Crews; Rufus Akinyemi; John Hardy; Andrew Singleton; Jose Bras
Journal: PLoS One Date: 2008-10-17 Impact factor: 3.240

9 in total

10 in total

Review 1. Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors: Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal: BMC Public Health Date: 2014-06-26 Impact factor: 3.295

2. Neurexin 2 p.G849D variant, implicated in Parkinson's disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells.

Authors: Katelyn Cuttler; Dalene de Swardt; Lize Engelbrecht; Jurgen Kriel; Ruben Cloete; Soraya Bardien
Journal: J Neural Transm (Vienna) Date: 2022-10-15 Impact factor: 3.850

Review 3. Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors: Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal: J Neurol Sci Date: 2016-05-06 Impact factor: 3.181

Review 4. Neuroscience-related research in Ghana: a systematic evaluation of direction and capacity.

Authors: Emmanuel Quansah; Thomas K Karikari
Journal: Metab Brain Dis Date: 2015-09-07 Impact factor: 3.584

5. Early-Onset Parkinson Disease Screening in Patients From Nigeria.

Authors: Lukasz M Milanowski; Olajumoke Oshinaike; Benjamin J Broadway; Jennifer A Lindemann; Alexandra I Soto-Beasley; Ronald L Walton; Rana Hanna Al-Shaikh; Audrey J Strongosky; Fabienne C Fiesel; Owen A Ross; Wolfdieter Springer; Shamsideen Abayomi Ogun; Zbigniew K Wszolek
Journal: Front Neurol Date: 2021-01-14 Impact factor: 4.003

Review 6. Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors: Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal: Front Neurosci Date: 2022-09-20 Impact factor: 5.152

10. Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.

Authors: Njideka U Okubadejo; Mie Rizig; Oluwadamilola O Ojo; Hallgeir Jonvik; Olajumoke Oshinaike; Emmeline Brown; Henry Houlden
Journal: PLoS One Date: 2018-12-03 Impact factor: 3.240